Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.

@article{LambertMesserlian1998SecondtrimesterMS,
  title={Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.},
  author={Geralyn M Lambert-Messerlian and Devereux N. Saller and M B Tumber and Charles A. French and C J Peterson and Jacob A. Canick},
  journal={Prenatal diagnosis},
  year={1998},
  volume={18 10},
  pages={
          1061-7
        }
}
  • Geralyn M Lambert-Messerlian, Devereux N. Saller, +3 authors Jacob A. Canick
  • Published in Prenatal diagnosis 1998
  • Medicine
  • The objective was to investigate whether cases of fetal trisomy 18 and Turner syndrome with and without hydrops were associated with alterations in the second-trimester levels of maternal serum inhibin A. Twenty-one cases of trisomy 18, 10 cases of Turner syndrome without hydrops and 12 cases of Turner syndrome with hydrops were identified. Five control samples were matched to each case for date of sample collection and completed week of gestation. Inhibin A levels were modestly, but… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 21 CITATIONS

    Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing.

    • Peter Benn
    • Medicine
    • Clinica chimica acta; international journal of clinical chemistry
    • 2002
    VIEW 15 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Simplifying the ultrasound findings of the major fetal chromosomal aneuploidies.

    VIEW 2 EXCERPTS
    CITES METHODS & BACKGROUND

    Prenatal screening for fetal aneuploidy in singleton pregnancies.

    Prenatal screening for fetal aneuploidy.